E. Kostouros

Oxaliplatin-Induced Neuropathy: A Long-Term Clinical and Neurophysiologic Follow-Up Study

Panagiotis Kokotis, Martin Schmelz, E. Kostouros et al. · Clinical Colorectal Cancer · 2016 · 56 citations

Medicine, Neurology, Oncology +14

Prognostic evaluation of tumour type and other histopathological characteristics in advanced epithelial ovarian cancer, treated with surgery and paclitaxel/carboplatin chemotherapy: Cell type is the most useful prognostic factor

Aristotelis Bamias, Maria Sotiropoulou, Flora Zagouri et al. · European Journal of Cancer · 2011 · 49 citations · Full text

Medicine, Oncology, Surgery +17

Expression and prognostic significance of VEGF and mTOR pathway proteins in metastatic renal cell carcinoma patients: a prognostic immunohistochemical profile for kidney cancer patients

Michalis Liontos, Eleni‐Andriana Trigka, Penelope Korkolopoulou et al. · World Journal of Urology · 2016 · 24 citations

Medicine, Oncology, Pathology +16

Prospective, randomized phase III study comparing two intensified regimens (methotrexate/vinblastine/doxorubicin hydrochloride/cisplatin [MVAC] versus gemcitabine/cisplatin) in patients with inoperable or recurrent urothelial cancer.

Aristotelis Bamias, Alexandra Karadimou, Sofia Lampaki et al. · Journal of Clinical Oncology · 2011 · 13 citations

Medicine, Oncology, Pharmacology +13